2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Ulf Landmesser; M. John Chapman; Jane K. Stock; Pierre Amarenco; Jill J. F. Belch; Jan Borén; Michel Farnier; Brian A. Ference; Stephan Gielen; Ian Graham; Diederick E. Grobbee; G. Kees Hovingh; Thomas F. Lüscher; Massimo F. Piepoli; Kausik K. Ray; Erik S. Stroes; Olov Wiklund; Stephan Windecker; Jose Luis Zamorano; Fausto Pinto; Lale Tokgözoglu; Jeroen J. Bax; Alberico L. Catapano

doi:https://doi.org/10.1093/eurheartj/ehx549

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Ulf Landmesser, M. John Chapman, Jane K. Stock, Pierre Amarenco, Jill J. F. Belch, Jan Borén, Michel Farnier, Brian A. Ference, Stephan Gielen, Ian Graham, Diederick E. Grobbee, G. Kees Hovingh, Thomas F. Lüscher, Massimo F. Piepoli, Kausik K. Ray, Erik S. Stroes, Olov Wiklund, Stephan Windecker, Jose Luis Zamorano, Fausto PintoLale Tokgözoglu, Jeroen J. Bax, Alberico L. Catapano

Research output: Contribution to journal › Article › Academic › peer-review

180 Citations (Scopus)

Original language	English
Pages (from-to)	1131–1143
Journal	European Heart journal
Volume	39
Issue number	14
Early online date	2017
DOIs	https://doi.org/10.1093/eurheartj/ehx549
Publication status	Published - 2018

Access to Document

https://doi.org/10.1093/eurheartj/ehx549

Cite this

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Lüscher, T. F., Piepoli, M. F., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L., ... Catapano, A. L. (2018). 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart journal, 39(14), 1131–1143. https://doi.org/10.1093/eurheartj/ehx549

@article{90690f2dde4a465ba0815de60bad2209,

title = "2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia",

author = "Ulf Landmesser and Chapman, {M. John} and Stock, {Jane K.} and Pierre Amarenco and Belch, {Jill J. F.} and Jan Bor{\'e}n and Michel Farnier and Ference, {Brian A.} and Stephan Gielen and Ian Graham and Grobbee, {Diederick E.} and Hovingh, {G. Kees} and L{\"u}scher, {Thomas F.} and Piepoli, {Massimo F.} and Ray, {Kausik K.} and Stroes, {Erik S.} and Olov Wiklund and Stephan Windecker and Zamorano, {Jose Luis} and Fausto Pinto and Lale Tokg{\"o}zoglu and Bax, {Jeroen J.} and Catapano, {Alberico L.}",

year = "2018",

doi = "https://doi.org/10.1093/eurheartj/ehx549",

language = "English",

volume = "39",

pages = "1131–1143",

journal = "European Heart journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "14",

}

Landmesser, U, Chapman, MJ, Stock, JK, Amarenco, P, Belch, JJF, Borén, J, Farnier, M, Ference, BA, Gielen, S, Graham, I, Grobbee, DE, Hovingh, GK, Lüscher, TF, Piepoli, MF, Ray, KK, Stroes, ES, Wiklund, O, Windecker, S, Zamorano, JL, Pinto, F, Tokgözoglu, L, Bax, JJ & Catapano, AL 2018, '2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia', European Heart journal, vol. 39, no. 14, pp. 1131–1143. https://doi.org/10.1093/eurheartj/ehx549

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. / Landmesser, Ulf; Chapman, M. John; Stock, Jane K. et al.
In: European Heart journal, Vol. 39, No. 14, 2018, p. 1131–1143.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

AU - Landmesser, Ulf

AU - Chapman, M. John

AU - Stock, Jane K.

AU - Amarenco, Pierre

AU - Belch, Jill J. F.

AU - Borén, Jan

AU - Farnier, Michel

AU - Ference, Brian A.

AU - Gielen, Stephan

AU - Graham, Ian

AU - Grobbee, Diederick E.

AU - Hovingh, G. Kees

AU - Lüscher, Thomas F.

AU - Piepoli, Massimo F.

AU - Ray, Kausik K.

AU - Stroes, Erik S.

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Zamorano, Jose Luis

AU - Pinto, Fausto

AU - Tokgözoglu, Lale

AU - Bax, Jeroen J.

AU - Catapano, Alberico L.

PY - 2018

Y1 - 2018

U2 - https://doi.org/10.1093/eurheartj/ehx549

DO - https://doi.org/10.1093/eurheartj/ehx549

M3 - Article

C2 - 29045644

SN - 0195-668X

VL - 39

SP - 1131

EP - 1143

JO - European Heart journal

JF - European Heart journal

IS - 14

ER -

Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J et al. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart journal. 2018;39(14):1131–1143. Epub 2017. doi: https://doi.org/10.1093/eurheartj/ehx549